Bank of America’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bank of America’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,738	Closed	-$11.1K	–	8595
2024 Q3	$11.1K	Sell	4,738 -444	-9%	-$896	﹤0.01%	6872
2024 Q2	$4.56K	Sell	5,182 -14,609	-74%	-$30.1K	﹤0.01%	7027
2024 Q1	$80.9K	Sell	19,791 -7,680	-28%	-$34.4K	﹤0.01%	6336
2023 Q4	$161K	Buy	+27,471	New	+$145K	﹤0.01%	6190
2023 Q1	–	Sell	-30	Closed	-$46	–	8392
2022 Q4	$46	Buy	+30	New	+$38	﹤0.01%	7820

Bank of America's AUGX Position: Q4 2024 in Review

Bank of America sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 4,738 shares — an estimated $11.1K sold.

Bank of America first reported a position in AUGX in Q4 2022 and held it in 5 quarters. The position peaked at $161K in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Bank of America reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Bank of America sold 4,738 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $11.1K.
Bank of America first reported a position in Augmedix, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
Bank of America's Augmedix, Inc. Common Stock position peaked at $161K in Q4 2023.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.